Replimune (REPL) Other Working Capital Changes (2020 - 2026)
Replimune (REPL) reported Other Working Capital Changes of -$234000.0 for Q1 2026, down 25.13% on a YoY basis from -$312557.1 in Q1 2025, and down 25.81% sequentially from -$186000.0 in Q4 2025.
Replimune (REPL) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Replimune (REPL) has 7 years of Other Working Capital Changes data on file, last reported at -$234000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 25.13% year-over-year to -$234000.0; the trailing twelve-month figure through Mar 2026 stood at -$818000.0 (down 13.61% YoY), and the FY2026 full-year result was -$818000.0, down 13.61% from the prior year.
- Other Working Capital Changes eased to -$234000.0 in Q1 2026, from -$186000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.2 million in Q3 2024 to a low of -$1.8 million in Q2 2024.
- A 5-year average of $188352.9 and a median of $140000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes jumped 555.22% in 2023 and plunged 3016.67% in 2025, its largest moves.
- Tracing REPL's Other Working Capital Changes over 5 years: stood at -$134000.0 in 2022, then jumped by 555.22% to $610000.0 in 2023, then plunged by 187.38% to -$533000.0 in 2024, then soared by 65.1% to -$186000.0 in 2025, then dropped by 25.81% to -$234000.0 in 2026.
- Business Quant data shows REPL's Other Working Capital Changes at -$234000.0 in Q1 2026, -$186000.0 in Q4 2025, and -$82000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -234,000.00 |
| Mar 31, 2026 | -234,000.00 |
| Mar 31, 2026 | -234,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | -316,000.00 |
| Jun 30, 2025 | -316,000.00 |
| Jun 30, 2025 | -316,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Mar 31, 2025 | -187,000.00 |
| Dec 31, 2024 | -533,000.00 |
| Dec 31, 2024 | -533,000.00 |
| Dec 31, 2024 | -533,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Sep 30, 2024 | 171,000.00 |